Home Articles

Articles

Welcome to the ARCHIVE of Pharma Marketing News articles. All articles are FREE! No subscription is required to download these articles from past issues. Articles become available to non-subscribers approximately two months after publication. To obtain articles as soon as they are published, you must subscribe to the email newsletter service. Subscription is free and supported by advertising.

PinUp: “Crushing” Pharma Via Lawsuits, Amazon, and Somewhat Unnecessary FDA Guidance

Welcome to the December 12, 2017, issue of Pharma Industry News Update (aka PinUp). You would think by now pharma marketers would be well versed in the correct product name placement, size, prominence, and frequency in promotional labeling and advertising for prescription drugs. Obviously not because the FDA recently released guidance on the topic.

Industry and Consumer Advocates Square Off Regarding Social Media

This article presents an overview of the types of organizations that submitted comments versus those that made presentations at the November 2009 public hearing. It also includes general comments from the pharma industry regarding the process by which the FDA should regulate the Internet and social media. Also presented in this article are the comments submitted by consumer advocates and individuals who generally supported more strict regulation across the board.

Sanofi US Diabetes Team Wins 3rd Annual Pharmaguy Social Media Pioneer Award

PharmaGuy (aka John Mack) presented the coveted bright yellow Hawaiian shirt/Pharmaguy Social Media Pioneer Award to Dennis Urbaniak, VP, Joan Mikardos, Senior Director, and Laura Kolodjeski, Senior Manager, Patient Solutions, at Sanofi US Diabetes. The award was made at the 6th Annual Digital Pharma East conference in Philadelphia on October 17, 2012. Accepting the award on behalf of the winners -- who could not make it in person -- was Wendy Blackburn of Intouch Solutions.

Patients with Chronic Conditions Are OK With Off-Label Drug Promotion: If FDA Allows It,...

This article summarizes the results of three surveys, which were presented at an FDA Part 15 hearing regarding 'Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products.'

Will COX-2 Inhibitors Crash and Burn?

This article documents the effect of the withdrawal of Vioxx and other COX-2 revelations on physicians' prescribing behavior using data from ImpactRx. Also included are results from a recent survey we conducted of Pharma Marketing News susbcribers regarding the wisdom of Pfizer's decision to test Celebrex to see if it is able to prevent heart attacks and strokes in patients with serious cardiovascular disease.

Communicating Risk: Let the Dialogue Begin

This article presents a lightly edited transcript of a Pharma Marketing Roundtable discussion of the March 31, 2006 Coalition for Healthcare Communication's Citizens Petition to the FDA seeking new prescription drug advertising rules to simply the communication of risk information in DTC ads.

Pharma Marketing News Vol. 10, No. 13: 23 August 2011

Welcome to Volume 10, Issue #13 (23 AUGUST 2011) of Pharma Marketing News.

Pfizer’s Chapstick Slapstick Facebook Fiasco

If pharma marketers are going to be successful engaging consumers (mostly women) via social media, then they need to be more sensitive about how they portray women in ads and very savvy about how they handle comments (if they allow comments).

Pharma Marketing News – Corporate Compliance/Government Regulation/Industry Guidelines

Pharma Marketing News is the monthly e-newsletter of the Pharma Marketing Network (www.pharma-mkting.com). It is packed with facts, opinions, and case studies based upon interviews with experts in the field of pharmaceutical marketing. Highlights of presentations from industry conferences, contact lists for experts consulted, and links to references help susbcribers keep up to date on best practices and network with their peers.

Finding the “Right Stuff” to Revitalize Sales Productivity

Declining sales force productivity is a major issue on the minds of sales managers and corporate executives of pharmaceutical companies large and small. More and more physicians are limiting face time and closing their doors to sales reps.The nature of sales detailing has changed over the years and the time has come to reassess the process and potential of this sales channel.

Pharma Marketing News, Blog Posts, Events, Podcasts

- Advertisement -